Papers
16
Total Citations
410
H-Index
11
About
Dr. Stefano Restaino is a pioneering gynecologic surgeon whose research centers on advancing minimally invasive surgery, particularly through the integration of robotic technologies for the treatment of endometriosis and endometrial cancer. His major contributions include landmark evaluations of the TELELAP ALF-X robotic system, demonstrating its feasibility and safety in hysterectomy and complex gynecologic procedures. He has authored highly cited systematic reviews and meta-analyses comparing robotic versus laparoscopic surgery, with his 2020 meta-analysis on endometriosis accumulating 75 citations. Dr. Restaino’s work has had substantial impact, evidenced by over 400 total citations across his top publications. Notably, he led the ROMANHY trial, a multicentric randomized study investigating the role of uterine manipulators in early-stage endometrial cancer staging, and has conducted large retrospective analyses involving more than 1,200 patients. His research also addresses surgical challenges in obese and frail populations, showcasing his commitment to improving outcomes for high-risk patients. Dr. Restaino’s contributions have helped shape contemporary guidelines and clinical decision-making in robotic gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10Robotic versus laparoscopic surgery in gynecology: which should we use?12 citations · 2016